Clinical trial Recruiting at 1 site Observational Ages 18 to 110

Machine learning and blood tests to detect delayed cerebral ischemia early

Official title: Machine Learning and Biomarkers for Early Detection of Delayed Cerebral Ischemia

Run by Sahlgrenska University Hospital · NCT06069973 · Data updated 2026-11-12

This project will test whether combining machine learning with brain-related blood markers and bedside monitoring can spot or predict delayed cerebral ischemia in adults with aneurysmal subarachnoid hemorrhage in intensive care.

Quick facts

Study typeObservational
Ages18 Years to 110 Years
SexAll
Enrollment1500 (estimated)
SponsorSahlgrenska University Hospital
Academic / other
Locations1 site (Gothenburg)
StatusRecruiting
StartedJanuary 1, 2024
Main results expectedDecember 31, 2033
Study endsDecember 31, 2033
Registry record updatedJanuary 12, 2026
Trial IDNCT06069973 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults (over 18) with aneurysmal subarachnoid hemorrhage admitted to the ICU at Sahlgrenska University Hospital who can consent and do not have prior brain damage or significant cardiac arrhythmia.

Probably not a fit

People with pre-existing brain damage, significant cardiac arrhythmias (who are excluded), or those not treated in the Sahlgrenska ICU would not be eligible and therefore would not directly benefit from participation.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This is an observational study of adults with aneurysmal subarachnoid hemorrhage admitted to the ICU at Sahlgrenska University Hospital. Researchers will collect serial blood and cerebrospinal fluid samples for neurospecific biomarkers (GFAP, NSE, total tau, S-100, neurofilament light chain) and continuously record physiologic signals including heart rate variability, EEG, near-infrared spectroscopy, and measures of cerebral autoregulation. Machine learning models will integrate these biomarkers and monitoring features to detect or predict episodes of delayed cerebral ischemia, and biomarker levels will be compared with long-term functional outcomes using the Glasgow Outcome Scale Extended at 1, 3, and 5 years. No interventional treatments are given as part of the protocol; data are intended to develop an early warning approach that could be deployed at the bedside if validated.

Why it matters

Potential benefit: If successful, this approach could give doctors an early warning of impending brain ischemia so they can intervene sooner and potentially reduce disability and death.

How similar studies have gone: Machine learning models using clinical and imaging data have shown promise for predicting delayed cerebral ischemia, but using blood and CSF neurospecific biomarkers combined with continuous physiologic monitoring for early detection remains novel and unproven.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

Patients over the age of 18 with aneurysmal subarachnoid hemorrhage admitted to intensive care units at Sahlgrenska University hospital.

Exclusion Criteria:

* Unable to consent,
* Cardiac arrythmia,
* Previous brain damage

Where it's running

  • Sahlgrenska University Hospital
    Gothenburg, Sweden
    Recruiting

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.